Puzo Michael J Lowers Stock Holdings in Roche Holding AG (OTCMKTS:RHHBY)

Puzo Michael J lessened its stake in shares of Roche Holding AG (OTCMKTS:RHHBY) by 1.1% in the 1st quarter, Holdings Channel.com reports. The firm owned 23,950 shares of the company’s stock after selling 275 shares during the quarter. Puzo Michael J’s holdings in Roche were worth $986,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also recently modified their holdings of the company. HighPoint Advisor Group LLC boosted its holdings in Roche by 2.8% in the 4th quarter. HighPoint Advisor Group LLC now owns 11,091 shares of the company’s stock valued at $387,000 after purchasing an additional 304 shares in the last quarter. Fulton Bank N.A. lifted its holdings in shares of Roche by 2.6% in the 1st quarter. Fulton Bank N.A. now owns 12,620 shares of the company’s stock valued at $518,000 after buying an additional 314 shares during the period. Confluence Investment Management LLC boosted its stake in shares of Roche by 3.6% in the first quarter. Confluence Investment Management LLC now owns 14,491 shares of the company’s stock valued at $596,000 after buying an additional 510 shares in the last quarter. Altrius Capital Management Inc grew its holdings in Roche by 0.3% during the fourth quarter. Altrius Capital Management Inc now owns 183,448 shares of the company’s stock worth $6,399,000 after acquiring an additional 603 shares during the period. Finally, Hancock Whitney Corp grew its holdings in Roche by 6.8% during the fourth quarter. Hancock Whitney Corp now owns 23,516 shares of the company’s stock worth $820,000 after acquiring an additional 1,496 shares during the period.

Wall Street Analyst Weigh In

Several equities research analysts have commented on the stock. HSBC lowered shares of Roche from a “buy” rating to a “hold” rating in a research report on Monday, April 28th. Hsbc Global Res cut Roche from a “strong-buy” rating to a “hold” rating in a research report on Monday, April 28th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, one has issued a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy”.

Roche Stock Down 0.3%

Shares of Roche stock opened at $40.02 on Wednesday. The business has a 50 day moving average price of $39.63 and a 200 day moving average price of $39.11. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.20 and a current ratio of 1.48. Roche Holding AG has a 1 year low of $33.76 and a 1 year high of $44.31.

Roche Company Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.